Green Hygienics (GRYN) 10-Q 14 Jan 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Oct. 31, 2021	Dec. 09, 2021
Cover [Abstract]
Entity Registrant Name	GREEN HYGIENICS HOLDINGS INC.
Entity Central Index Key	0001443388
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--07-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Oct. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Entity Common Stock Shares Outstanding		44,482,138
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity File Number	000-54338
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	26-2801338
Entity Address Address Line 1	13795 Blaisdell Place
Entity Address Address Line 2	Suite 202
Entity Address City Or Town	Poway
Entity Address State Or Province	CA
Entity Address Postal Zip Code	92064
City Area Code	1-855
Local Phone Number	802-0299

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Oct. 31, 2021	Jul. 31, 2021
Current Assets
Cash	$ 34,847	$ 507,512
Deposit	10,000	0
Inventory	175,957	0
Total Current Assets	220,804	507,512
Fixed Assets, net (Note 3)	5,494,912	5,522,326
Intangible Assets	25,000	25,000
Total Assets	5,740,716	6,054,838
Current Liabilities
Accounts payable and accrued liabilities	396,160	749,592
Payroll Liability	403,503	304,383
Accounts payable - related parties (Note 7)	648,638	523,791
Accrued interest payable	64,937	58,953
Current portion of long-term debt (Note 5)	3,562,038	3,557,594
Due to related parties (Note 7)	3,473,720	3,128,463
Total Current Liabilities	8,548,996	8,322,776
Long Term Liabilities
Notes payable (less current portion) (Note 5)	49,694	65,891
Mortgage payable (Note 5)	2,750,000	2,750,000
Second Mortgage payable (Note 5)	1,760,000	1,760,000
Total Long-Term Liabilities	4,559,694	4,575,591
Total Current and Long-Term Liabilities	13,108,690	12,898,367
Stockholder's Deficit
Common stock, 375,000,000 shares authorized, $0.001 par value 44,482,138 and 44,126,138 shares issued and outstanding, respectively	44,482	44,126
Stock payable	100,000	812,000
Additional paid-in capital	51,977,994	51,186,075
Deficit	(59,490,450)	(58,885,730)
Total Stockholder's Deficit	(7,367,974)	(6,843,529)
Total Liabilities and Stockholder's Deficit	$ 5,740,716	$ 6,054,838

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 31, 2021	Jul. 31, 2021
Stockholder's Deficit
Common stock, shares authorized	375,000,000	375,000,000
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares issued	44,482,138	44,126,138
Common stock, shares outstanding	44,482,138	44,126,138

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (unaudited) - USD ($)	3 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Condensed Consolidated Statements of Operations (unaudited)
Rental Revenue	$ 4,500	$ 40,954
Operating Expenses
Consulting and Business Development	154,655	85,991
Stock based compensation	0	1,904,950
Supplies		4,746
Payroll and subcontractor expenses	157,500	52,500
General and administrative	179,828	231,048
Total Operating Expenses	491,983	2,279,235
Loss Before Other Income (Expense)	(487,483)	(2,238,281)
Other Income (Expense)
Interest expense	(297,237)	(191,440)
Gain on forgiveness of payable (Note 11)	180,000	0
Total Other Income (Expense)	(117,237)	(191,440)
Net Loss	$ (604,720)	$ (2,429,721)
Net Loss Per Share, Basic and Diluted	$ (0.01)	$ (0.06)
Weighted Average Shares Outstanding	44,482,138	40,956,924

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock Payable [Member]	Accumulated Deficit [Member]
Balance, shares at Jul. 31, 2020		39,577,781
Balance, amount at Jul. 31, 2020	$ (4,432,520)	$ 39,758	$ 45,830,289	$ 192,000	$ (50,494,387)
Imputed interest	76,778	$ 0	76,778	0	0
Shares issued for services, shares		2,000,000
Shares issued for services, amount	1,904,050	$ 2,000	1,994,050	(92,000)	0
Shares issued for prepaid expenses, shares		150,857
Shares issued for prepaid expenses, amount	155,383	$ 151	155,232
Shares issued for acquisition of fixed assets, shares		190,000
Shares issued for acquisition of fixed assets, amount	188,700	$ 190	188,510
Net loss	(2,429,721)	$ 0	0	0	(2,429,721)
Balance, shares at Oct. 31, 2020		41,918,638
Balance, amount at Oct. 31, 2020	(4,537,330)	$ 41,919	48,244,859	100,000	(52,924,108)
Balance, shares at Jul. 31, 2020		39,577,781
Balance, amount at Jul. 31, 2020	(4,432,520)	$ 39,758	45,830,289	192,000	(50,494,387)
Shares issued for prepaid expenses, amount	$ 69,600
Shares issued Private Placement, shares	50,000
Balance, shares at Jul. 31, 2021		44,126,138
Balance, amount at Jul. 31, 2021	$ (6,843,529)	$ 44,126	51,186,075	812,000	(58,885,730)
Imputed interest	80,275	$ 0	80,275	0	0
Shares issued for services, amount	0
Net loss	(604,720)		0	0	(604,720)
Shares issued Private Placement, shares		356,000
Shares issued Private Placement, amount	0	$ 356	711,644	(712,000)	0
Balance, shares at Oct. 31, 2021		44,482,138
Balance, amount at Oct. 31, 2021	$ (7,367,974)	$ 44,482	$ 51,977,994	$ 100,000	$ (59,490,450)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Operating Activities
Net loss	$ (604,720)	$ (2,429,721)
Imputed interest	80,275	76,778
Depreciation expense	62,439	30,177
Share based compensation	0	1,904,050
Non cash interest	0	716
Common stock issued for vehicles	0	1,500
Foreign Currency losses	1,321	0
Amortization of Note Discount	4,444	0
Changes in operating assets and liabilities:
Other Current Assets	(10,000)	0
Inventory	(175,957)	(291,928)
Accrued interest payable	5,984	(117,639)
Accounts payable, accrued liabilities and payroll liabilities	(254,312)	119,609
Accounts payable - related party	124,847	27,500
Deferred revenue	0	(15,973)
Net Cash Used in Operating Activities	(765,679)	(694,931)
Investing Activities
Cash paid for purchase of fixed assets	(35,025)	(29,833)
Net Cash Used in Investing Activities	(35,025)	(29,833)
Financing Activities
Payments on discounted note payable		(171,213)
Payments on related parties loans	(77,913)	(70,000)
Principle payments on notes payable	(15,897)	(7,149)
Advances from related parties	421,849	1,013,500
Net Cash Provided by Financing Activities	328,039	765,138
(Decrease) Increase in cash	(472,665)	40,374
Cash, Beginning of Period	507,512	40,538
Cash, End of Period	34,847	80,912
Supplemental Disclosures:
Interest paid	207,328	230,036
Non-Cash Transactions
Shares issued for prepaid expenses	0	155,383
Shares issued for stock payable	712,000	92,000
Shares issued for vehicles	$ 0	$ 188,700

Nature of Operations and Contin

Nature of Operations and Continuance of Business	3 Months Ended
	Oct. 31, 2021
Nature of Operations and Continuance of Business
Note - 1 Nature of Operations and Continuance of Business	1. Nature of Operations and Continuance of Business Green Hygienics Holdings Inc. (the “Company”) was incorporated in the State of Nevada on June 12, 2008 as Silver Bay Resources, Inc. On June 30, 2010, the name was changed to Takedown Entertainment Inc. On July 24, 2012, the Company changed its name to Green Hygienics Holdings Inc. The Company is an innovative, full-scope, science-driven, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for cannabidiol (“CBD”). The Hemp Farming Act of 2018 removed hemp from Schedule I controlled substances (defined as cannabis with less than 0.3% THC), making it an ordinary agricultural commodity. The Company’s business model includes generating revenues from the sale of hemp and premium-grade CBD products, creating trusted global consumer brands, developing valuable Intellectual Property, and growing the Company rapidly through strategic acquisitions. With direct regard to acquisitions, the Company acts as a business accelerator and a vertical integrator focusing to support rapid growth and development of companies with extraordinary potential. A novel strain of coronavirus (“COVID-19”) continues to spread and severely impact the economy of the United States and other countries around the world. Federal, state, and local governmental policies and initiatives designed to reduce the transmission of COVID-19 have resulted in, among other things, matters related to our ability to increase sales to existing and new customers, continue to perform on existing contracts, develop and deploy new technologies, expand our marketing capabilities and sales organization, the adoption of work-from-home or shelter-in-place policies. and to generate sufficient cash flow to operate our business and meet our obligations. The COVID-19 impact on the Company’s operations is consistent with the overall industry and publicly issued statements from competitors, partners, and vendors. More generally, the COVID-19 pandemic has and is expected to continue to adversely affect economies and financial markets globally, leading to a continued economic downturn, which is expected to decrease spending generally and could adversely affect demand for our products. It is not possible at this time to estimate the full impact that COVID-19 will have on our business, as the impact will depend on future developments which are highly uncertain and cannot be predicted. The extent to which our businesses may be affected by the COVID-19 pandemic will largely depend on both current and future developments, including its duration, spread, and treatment, including vaccines in various stages of development and federal approval, and related work and travel advisories and restrictions, all of which are highly uncertain and cannot be reasonably predicted at this time. Going Concern These condensed consolidated unaudited financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has generated limited revenues since 2013. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to continue operations, and the attainment of profitable operations. As of October 31, 2021, the Company has a working capital deficiency of $8,328,192and has an accumulated deficit of $59,490,450. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Oct. 31, 2021
Significant Accounting Policies
Note - 2 Significant Accounting Policies	2. Significant Accounting Policies (a) Basis of Presentation These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. Certain amounts from the July 31, 2021 annual report have been reclassified to conform to the presentation used in the current period. (b) Principles of Consolidation These financial statements include the accounts of the Company and its subsidiaries. Subsidiaries are all entities (including structured entities) which the Company controls. For accounting purposes, control is established by an investor when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. All inter-company balances and transactions are eliminated. (c) Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. (d) Cash and Cash Equivalents The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance and trust funds to be cash equivalents. (e) Inventory Inventory is carried at the lower of cost or net realizable value, with the cost being determined on a first-in, first-out (FIFO) basis. The Company periodically reviews physical inventory and will record a reserve for excess and/or obsolete inventory if necessary. During the three months end October 31, 2021, the company harvested approximately 30,000 and 40,000 pounds of flower and a great deal more of seconds and biomass. During the three months ended October 31, 2021, the Company recognized inventory costs of $175,956 includes raw materials, labor, overhead and other. (f) Impairment of Long-Lived Assets The Company evaluates the recoverability of its fixed assets and other assets in accordance with ASC 360-10-15, Impairment or Disposal of Long-Lived Assets (g) Related Party Transactions The Company follows ASC 850, Related Party Disclosures (h) Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. (i) Foreign Currency Translation The Company’s functional and reporting currency is the U.S. dollar. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in the statement of operations. (j) Financial Instruments and Fair Value Measures ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, loans payable, and amounts due to related parties. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. (k) Stock-based Compensation The Company records stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” and ASC 505, “Equity Based Payments to Non-Employees”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. (l) Revenue and Deferred Revenue In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) which amended the existing accounting standards for revenue recognition. ASU 2014-09 establishes principles for recognizing revenue upon the transfer of promised goods or services to customers, in an amount that reflects the expected consideration received in exchange for those goods or services. As of the date of this report, the Company has not recognized any revenue related to the hemp production business. For the three months ended October 31, 2021, the company recognized $4,500 in rental income from San Diego Gas and Electric Company (“SDGE”) for land usage. For the three months ended October 31, 2020, revenue recognized of $40,954 is related to the land use rental income from SDGE. SDGE vacated the property in October 2020. As of July 31, 2020, the Company recorded deferred revenue of $15,973, representing a portion of the payment received in July 2020, that pertains to August 2020 rental income and accordingly has been recognized and is included in the revenue for the three months ended October 31, 2020. (m) Leases The Company evaluates lease assets and lease liabilities, (if any), pursuant to ASC 842, by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing transactions. As of the date of this report, the Company has no material transactions to report. (n) Loss Per Share The Company computes earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of October 31, 2021, the Company does not have any potentially dilutive shares. (o) Comprehensive Loss ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. (p) Recent Accounting Pronouncements In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases. The amendments in ASU 2018-10 provide additional clarification and implementation guidance on certain aspects of the previously issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) and have the same effective and transition requirements as ASU 2016-02. Upon the effective date, ASU 2018-10 will supersede the current lease guidance in ASC Topic 840, Leases. Under the new guidance, lessees will be required to recognize for all leases, with the exception of short-term leases, a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis. Concurrently, lessees will be required to recognize a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ASU 2018-10 is effective for private companies and emerging growth public companies for interim and annual reporting periods beginning after December 15, 2019, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. During the three months ended October 31, 2021, the Company assessed the impact this guidance had on its financial statements and concluded that at present ASU No. 2018-10 has no impact on its financial statements.

Prepaid expenses

Prepaid expenses	3 Months Ended
	Oct. 31, 2021
Prepaid expenses
Note - 3 Prepaid expenses	3. Prepaid expenses On September 13, 2020, and concurrently with the execution of the Financing Agreement, the Company issued to GHS Investments, LLC, 150,857 restricted shares of its common stock (“Commitment Shares”) to offset transaction costs. The shares were valued at $155,383 based on OTC’s closing trade price on the date of the agreement and were recorded as a prepaid expense on the condensed consolidated balance sheets presented herein. The prepaid expense was fully expensed as of July 31, 2021 as the financing did not consummate due to unfavorable market conditions. For the three months ended October 31, 2021, the company did not recognize any prepaid expenses.

Fixed Assets

Fixed Assets	3 Months Ended
	Oct. 31, 2021
Fixed Assets
Note - 4 Fixed Assets	4. Fixed Assets Fixed assets are recorded at cost reduced by accumulated depreciation. Depreciation expense is recognized over the assets’ estimated useful lives using the straight-line method. Estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset lives may be adjusted and an impairment assessment may be performed on the recoverability of the carrying amounts. Fixed assets consist of the following: Useful Life Balance at July 31, 2021 Additions Accumulated Depreciation Balance at October 31, 2021 Production equipment 5 years $ 854,899 $ 35,023 $ (53,848 ) $ 836,785 Furniture and office equipment 5 years 4,859 - (408 ) 4,451 Buildings and improvements 15 years 450,206 - (8,183 ) 442,023 Land 4,212,362 - - 4,212,362 $ 5,522,326 $ 35,023 $ (62,439 ) $ 5,494,912 Fixed asset costs are being depreciated using the straight-line method based on the useful life of the asset. Depreciation expenses was $62,439 and $30,177 for the three months ended October 31, 2021, and 2020, respectively.

Loans Payable

Loans Payable	3 Months Ended
	Oct. 31, 2021
Loans Payable
Note - 5 Loans Payable	5. Loans Payable The Company has the following notes payable outstanding as of October 31, 2021, and July 31, 2021: October 31, 2021 July 31, 2021 Secured Promissory Note payable, interest at 15%, matures August 15, 2024 $ 1,760,000 $ 1,760,000 Secured Promissory Note payable, interest at 6%, matures August 23, 2024 2,750,000 2,750,000 Promissory Note, interest at 5.66%, matures October 1, 2023 96,116 112,012 Paycheck Protection Program loan 444,850 444,850 Secured Promissory Note Payable, Interest at 15%, matures June 15, 2022, net of discount $4,119 2,664,629 2,660,186 Promissory Note, interest at 4.75%, matures March 2, 2022 406,137 406,137 Sub- total notes payable 8,121,732 8,133,185 Less long-term portion 4,559,694 7,235,776 Current portion of notes payable $ 3,562,038 $ 897,409 On August 15, 2019, the Company entered into a Secured Promissory Note with a face value of $1,760,000, with a non-related party. The note requires monthly payments of interest only at the rate of 15% per annum. The note is secured by a second charge on the Deed of Trust on real property commonly known as Round Potrero Road, Potrero, California. The maturity date of the debt is August 15, 2024. On August 23, 2019, the Company entered into a Secured Promissory Note with a face value of $2,750,000, with a non-related party. The note requires monthly payments of interest only at the rate of 6% per annum. The note is secured by a Deed of Trust on real property commonly known as Round Potrero Road, Potrero, California. The maturity date of the debt is August 23, 2024. On September 12, 2019, the Company entered into a Promissory Note with a face value of $183,031 with a non-related party for the purchase of equipment. The note requires monthly payments of $4,290 including interest at the rate of 5.66% per annum for a period of 48 months commencing November 1, 2019. The loan is secured by a collateral charge on production equipment. Of the amount owed, $46,422 is included in current liabilities and $65,591 is included in long-term liabilities on the consolidated balance sheet presented herein. On April 30, 2020 the Company received loan proceeds in the amount of $444,850 under the Paycheck Protection Program (“PPP”). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. The loans and accrued interest are forgivable after eight weeks as long as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and maintains its payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates employees or reduces salaries during the eight-week period. The unforgiven portion of the PPP loan is payable over two years at an interest rate of 1%, with a deferral of payments for the first six months. The Company believes it has used the proceeds for purposes consistent with the PPP, however, we cannot assure you that the Company will be eligible for forgiveness of the loan, in whole or in part. On December 15, 2020, the Company entered into a Secured Promissory Note with a face value of $2,668,748, with the same lender of the August 23, 2019, Secured Promissory Note. The principal balance of the note included an initial debt discount of $25,688, that will be amortized to interest expense over the term of the note. For the three months ended October 31, 2021, the Company recorded $100,078 of interest expense. As of October 31, 2021, there remains $4,119 of unamortized debt discount. The note requires monthly payments of interest only at the rate of 15% per annum. The note is secured by a third Deed of Trust on real property commonly known as Round Potrero Road, Potrero, California. The maturity date of the debt is June 15, 2022. A portion of the face value of this note was used to repay $1,140,000 of related party amounts due (see Note 7). On March 2, 2021, the Company entered into a Promissory Note with a face value of $406,137 related to the Asset Purchase Agreement with Primordia. The note carries an interest rate of 4.75% per annum and matures with a balloon a payment of principal and all accrued and unpaid interest on March 2, 2022. As of October 31, 2021, interest expense was $4,863.

Convertible Note Payable

Convertible Note Payable	3 Months Ended
	Oct. 31, 2021
Convertible Note Payable
Note - 6 Convertible Note Payable	6. Convertible Note Payable On December 19, 2019, the Company entered into an securities purchase agreement, which was amended on January 8, 2020 (collectively, the “SPA”) with Triton Funds, LP, an accredited investor (“Triton”), pursuant to which the Company issued and sold to Triton (i) a discounted convertible promissory note (the “Note”) in the aggregate principal amount of up to $750,000, due June 30, 2020, bearing interest at a rate of ten percent (10%) per annum and convertible into shares of the Company’s common stock at a conversion price of $2.50 per share and (ii) a common stock purchase warrant (the “Warrant”), exercisable for two (2) years, to purchase up to 250,000 shares of the Company’s common stock at an exercise price of $3.00 per share, subject to adjustment, for an aggregate purchase price of $600,000. If not exercised, the Warrant will expire at 5:00 pm EST on December 31, 2021. The Note can be prepaid at any time by paying 110% of the then outstanding principal, interest, default interest (if any), and any other amounts then due under the Note. The Note is initially convertible at a price per share equal to $2.50 (the “Fixed Conversion Price”); provided, however, that during the continuance of an event of default under the Note, the conversion price shall be equal to 75% of the lowest trading price of the Company’s common stock during the 30 trading days prior to conversion. On December 31, 2019, Triton paid an initial purchase price of $100,000 at the initial closing. The Company received net proceeds of $85,000 after paying fees of $15,000. On February 20, 2020, Triton paid the purchase price balance of $500,000. The original issue discount on the Note is a total of $150,000. On March 31, 2020, the Company and Triton entered into a Modification Agreement, pursuant to which (i) the Company paid $250,000 of the principal amount of the Note, bringing the principal balance of the Note on that date to $500,000, (ii) the maturity date of the Note was extended to August 20, 2020, (iii) the conversion price of the Note was established as 75% of the lowest trading price of our common stock during the 30 trading days prior to conversion, and (iv) the minimum volume weighted price requirement of the Note was deleted. On August 19, 2020, the Company paid the remaining principal and accrued and unpaid interest in the aggregate of $200,000 and as of that date the note balance is $-0-.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Oct. 31, 2021
Related Party Transactions
Note - 7 Related Party Transactions	7. Related Party Transactions Controlling Shareholder As of October 31, 2021, Alita Capital, Inc., together with its affiliates (collectively, “Alita”), is the controlling shareholder of the Company’s common stock, as Alita owns approximately 50% of our issued and outstanding common stock, Accordingly, Alita has the ability to exercise significant control over our affairs, including the election of directors and most actions requiring the approval of shareholders, including the approval of any potential merger or sale of all or substantially all assets or segments of the Company, or the Company itself. Alita is controlled by Mr. Ron Loudoun, the Company’s Chief Executive Officer. Alita is subject to certain restrictions under federal securities laws on sales of its shares as an affiliate. Should Alita sell or otherwise dispose of all or a portion of its position in the Company, a change in ownership and control of the Company could occur. A change in ownership, as defined by Internal Revenue Code Section 382, could reduce the availability of the Company’s net operating losses (“NOLs”) for federal and state income tax purposes. Furthermore, a change of control could trigger the change of control provisions in a number of our material agreements. During the three months ended October 31, 2021, Alita made advances to the Company (including direct payments to vendors) and received reimbursements from the Company as follows: Balance July 31, 2021 $ 3,128,462 Advances 423,171 Reimbursements (77,913 ) Balance October 31, 2021 $ 3,473,720 The above balances as of October 31, 2021, and July 31, 2021, are presented in due to related parties on the condensed consolidated balance sheets presented herein. Imputed interest of $80,275 and $76,778 for the three months ended October 31, 2021, and 2020, respectively, has been recorded for the above related party debts with the offset to additional paid in capital. Management Fees and accounts payable – related parties For the three months ended October 31, 2021, and 2020, the Company recorded expenses to its officers and former officers in the following amounts: Three months ended October 31, 2021 Three months ended October 31, 2020 CEO, parent $ 90,000 $ 22,500 Chief Technology Officer 7,500 7,500 Chief Financial Officer 22,500 Chief Project Manager 22,500 Chief Communications Manager 15,097 Chief Operating Officer 22,500 22,500 $ 180,097 $ 52,500 For the three months ended October 31, 2021, the activity for expenses recognized expenses and payments to officers and former officers as follows: Balance at July 31, 2021 Additions Payments Balance at October 31, 2021 CEO, parent $ 180,000 $ 90,000 $ - $ 270,000 Chief Technology Officer (7,500 ) 7,500 5,000 (5,000 ) Chief Operating Officer 113,679 22,500 28,500 107,679 Chief Financial Officer - 22,500 4,250 18,250 Chief Project Manager 40,468 22,500 7,500 55,468 Chief Communications Officer - 15,097 10,000 5,097 Former CEO, subsidiary 67,500 - - 67,500 Former President, subsidiary 67,500 - - 67,500 Former Chief Agricultural Officer, subsidiary 27,144 - - 27,144 Former Director 35,000 - - 35,000 $ 523,791 $ 180,097 $ 55,250 $ 648,638 All of the above amounts are non-interest bearing, unsecured and due on demand, and are presented in accounts payable related parties on the condensed consolidated balance sheets presented herein. Other On September 21, 2020, the Company issued 50,000 shares of common stock in the aggregate to two relatives of our Chief Project Manager (the “CPM”) in exchange for production equipment, pursuant to a Stock Purchase Agreement dated September 3, 2020, with an effective date of January 31, 2020. The shares were valued at $51,500 based on OTC’s closing trade price on the date of the agreement (see Note 8).

Share Issuances

Share Issuances	3 Months Ended
	Oct. 31, 2021
Share Issuances
Note - 8 Share Issuances	8. Share Issuances On September 2, 2020, the Company issued 500,000 common shares to SRAX, Inc. (“SRAX”), in exchange for the right to use the SRAX Sequire platform, pursuant to a Platform Account Contract dated August 4, 2020. The shares were valued at $355,550 based on OTC’s closing trade price on the date of the agreement. On September 13, 2020, and concurrently with the execution of the Financing Agreement, the Company issued to GHS Investments, LLC, 150,857 restricted shares of its Common stock (the “Commitment Shares”) to offset transaction costs (see Note 9 (o)). The shares were valued at $155,383 based on OTC’s closing trade price on the date of the agreement and were recorded as a prepaid expense on the condensed consolidated balance sheets presented herein. The expense will be recognized upon the Company selling shares of common stock to GHS under the equity line (see Note 9 (o)). On September 21, 2020, the Company issued 250,000 shares of common stock to the CEO of the Company in exchange for consulting services, pursuant to his agreement dated August 1, 2019 (see Note 9 (b)). The shares were valued at $370,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 100,000 shares of common stock to the Company’s CPM in exchange for consulting services, pursuant to his consulting agreement dated August 1, 2019 (see Note 9 (c)). The shares were valued at $148,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 50,000 shares of common stock in the aggregate to two relatives of our CPM in exchange for production equipment, pursuant to a Stock Purchase Agreement dated September 3, 2020, with an effective date of January 31, 2020. The shares were valued at $51,500 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 100,000 shares of common stock to the Chief Science Officer of the Company pursuant to his employment agreement dated August 1, 2020 (see Note 9 (l)). The shares were valued at $87,250 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 25,000 common shares to the Assistant Agricultural Operations Manager of the Company in exchange for consulting services, pursuant to her consulting agreement dated August 1, 2019 (see Note 9 (e)). The shares were valued at $37,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 200,000 shares of common stock pursuant to a consulting agreement dated July 1, 2020. The value of the shares of $92,000 was recorded against stock payable. On September 21, 2020 and under the terms of the Placement Agreement dated September 18, 2020, with Boustead Securities LLC (“BSL”), the Company issued to BSL an advisory fee of two hundred fifty thousand (250,000) shares of common stock (see Note 9 (p)). The shares were valued at $187,500 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 50,000 shares to the Company’s CFO, pursuant to his consulting agreement dated February 13, 2020 (see Note 9 (i)). The shares were valued at $60,750 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 50,000 shares of common stock to a consultant for advice on real estate acquisitions, pursuant to his consulting agreement (see Note 9 (n)). The shares were valued at $58,500 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 125,000 shares of common stock to a consultant for advisory services to the Board of Directors of the Company, pursuant to his consulting agreement (see Note 9 (j)). The shares were valued at $113,750 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 125,000 shares of common stock to a consultant for advisory services to the Board of Directors of the Company, pursuant to his consulting agreement (see Note 9 (k)). The shares were valued at $113,750 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 100,000 shares of common stock to a consultant for services, pursuant to his agreement dated February 1, 2020 (see Note 9 (h)). The shares were valued at $187,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 125,000 shares of common stock to a shareholder for advisory services to the Company, pursuant to his consulting agreement August 1, 2019 (see Note 9 (d)). The shares were valued at $185,000 based on OTC’s closing trade price on the date of the agreement. On September 29, 2020, the Company issued 140,000 shares of common stock to a non-related third party for the purchase of farm vehicles, pursuant to a Stock Purchase Agreement dated July 27, 2020, and effective June 1, 2020. The shares were valued at $137,200 based on OTC’s closing trade price on the effective date of the agreement.

Commitments Contingencies

Commitments Contingencies	3 Months Ended
	Oct. 31, 2021
Commitments Contingencies
Note - 9 Commitments/Contingencies	9. Commitments/Contingencies As of October 31, 2021, the Company has 375,000,000 shares of $0.001 par value common stock authorized and there are 44,482,138 shares of common stock issued and outstanding. As of the period ended October 31, 2021, the Company issued the following shares: On September 2, 2020, the Company issued 500,000 common shares to SRAX, Inc. (“SRAX”), in exchange for the right to use the SRAX Sequire platform, pursuant to a Platform Account Contract dated August 4, 2020. The shares were valued at $355,550 based on OTC’s closing trade price on the date of the agreement. The term of the contract was for one year, and accordingly, the Company has included the $355,550 in stock-based compensation expense. On September 13, 2020, and concurrently with the execution of the Financing Agreement, the Company issued to GHS Investments, LLC, 150,857 restricted shares of its Common stock (the “Commitment Shares”) to offset transaction costs. The shares were valued at $155,383 based on OTC’s closing trade price on the date of the agreement and were initially recorded as a prepaid expense. As a result of the Company not selling any shares to GHS, and may not occur in the future, the Company recognized $155,383 as stock-based compensation expense. On September 21, 2020, the Company issued 250,000 shares of common stock to the CEO of the Company in exchange for consulting services, pursuant to his agreement dated August 1, 2019. The shares were valued at $370,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 100,000 shares of common stock to the Company’s CPM in exchange for consulting services, pursuant to his consulting agreement dated August 1, 2019 (see Note 9 (c)). The shares were valued at $148,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 100,000 shares of common stock to the Chief Science Officer of the Company pursuant to his employment agreement dated August 1, 2020. The shares were valued at $87,250 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 25,000 common shares to the Assistant Agricultural Operations Manager of the Company in exchange for consulting services, pursuant to her consulting agreement dated August 1, 2019. The shares were valued at $37,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 200,000 shares of common stock pursuant to a consulting agreement dated July 1, 2020. The value of the shares of $92,000 was recorded against stock payable. On September 21, 2020 and under the terms of the Placement Agreement dated September 18, 2020, with Boustead Securities LLC (“BSL”), the Company issued to BSL an advisory fee of two hundred fifty thousand (250,000) shares of common stock. The shares were valued at $187,500 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 50,000 shares to the Company’s CFO, pursuant to his consulting agreement dated February 13, 2020. The shares were valued at $60,750 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 50,000 shares of common stock to a consultant for advice on real estate acquisitions, pursuant to his consulting agreement. The shares were valued at $58,500 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 125,000 shares of common stock to a consultant for advisory services to the Board of Directors of the Company, pursuant to his consulting agreement. The shares were valued at $113,750 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 125,000 shares of common stock to a consultant for advisory services to the Board of Directors of the Company, pursuant to his consulting agreement. The shares were valued at $113,750 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 100,000 shares of common stock to a consultant for services, pursuant to his agreement dated February 1, 2020. The shares were valued at $187,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 125,000 shares of common stock to a shareholder for advisory services to the Company, pursuant to his consulting agreement August 1, 2019. The shares were valued at $185,000 based on OTC’s closing trade price on the date of the agreement. On September 21, 2020, the Company issued 50,000 shares of common stock in the aggregate to two relatives of our CPM in exchange for production equipment, pursuant to a Stock Purchase Agreement dated September 3, 2020, with an effective date of January 31, 2020. The shares were valued at $51,500 based on OTC’s closing trade price on the date of the agreement. On September 29, 2020, the Company issued 140,000 shares of common stock to a non-related third party for the purchase of farm vehicles, pursuant to a Stock Purchase Agreement dated July 27, 2020, and effective June 1, 2020. The shares were valued at $137,200 based on OTC’s closing trade price on the effective date of the agreement. On November 15, 2020, the Company issued 100,000 shares of restricted common stock to a consultant, pursuant to a consulting agreement dated November 15, 2019, for services performed as COO of the Company. The shares were valued at $200,000 based on OTC’s closing trade price on the effective date of the agreement. On November 15,2020, the Company issued 125,000 shares of restricted common stock to a consultant, pursuant to a consulting agreement dated August 18, 2020. The shares were valued at $75,000 based on OTC’s closing trade price on the issuance date, pursuant to the agreement. On December 1, 2020, the Company issued 50,000 shares of restricted common stock to a consultant, pursuant to a consulting agreement dated December 1, 2020, for services performed as Corporate Communications Officer of the Company. The shares were valued at $34,000 based on OTC’s closing trade price on the effective date of the agreement. On January 15, 2021, the Company issued 100,000 shares of restricted common stock to a consultant, pursuant to a consulting agreement dated January 15, 2021, for services performed. The shares were valued at $75,000 based on OTC’s closing trade price on the effective date of the agreement. On February 17, 2021, the Company issued 125,000 shares of restricted common stock to a consultant, pursuant to a consultant agreement dated February 1, 2021, for services performed. The shares were valued at $113,750 based on OTC’s closing trade price on the effective date of the agreement. On February 17, 2021, the Company issued 200,000 shares of restricted common stock to a consultant, pursuant to a consultant agreement dated August 1, 2019, for services performed. The shares were valued at $296,000 based on OTC’s closing trade price on the effective date of the agreement. On March 10, 2021, the Company recorded the issuance in the aggregate of 200,000 shares of restricted common stock to two consultants, pursuant to a consultant agreement dated March 10, 2021, for services performed. The shares were valued at $206,000 based on OTC’s closing trade price on the effective date of the agreement. On March 11, 2021, the Company recorded the issuance in the aggregate of 60,000 shares of restricted common stock pursuant to an Asset Purchase Agreement between the Company and Castillo for the purchase of certain assets. The shares were valued at $69,600 based on OTC’s closing trade price on the effective date of the agreement and the Company recorded inventory of $69,400. On March 15, 2021, the Company recorded the issuance of 260,000 shares of restricted common stock pursuant to a consultant agreement dated March 15, 2021, for services performed. The shares were valued at $338,000 based on OTC’s closing trade price on the effective date of the agreement. On June 8, 2021, the Company issued 75,000 shares of restricted common stock pursuant to a consulting agreement dated May 1, 2021, for services. The shares were valued at $97,500 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 125,000 shares of common stock to the CEO of the Company in exchange for consulting services, pursuant to his agreement dated August 1, 2019. The shares were valued at $185,000 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 100,000 shares of restricted common stock to a consultant, pursuant to a consulting agreement dated November 15, 2019, for services performed as COO of the Company. The shares were valued at $200,000 based on OTC’s closing trade price on the effective date of the agreement. On June 8, 2021, the Company issued 100,000 shares of common stock to the Chief Science Officer of the Company pursuant to his employment agreement dated August 1, 2020. The shares were valued at $87,250 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 50,000 shares of common stock to a non-related party consultant in exchange for consulting services pursuant to a February 1, 2021 agreement. The shares were valued at $44,500 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 12,500 shares of common stock to a non-related party consultant in exchange for consulting services pursuant to a March 1, 2021 agreement. The shares were valued at $15,125 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 100,000 shares of common stock to a non-related party consultant in exchange for consulting services pursuant to a March 15, 2021 agreement. The shares were valued at $130,000 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 100,000 shares of common stock to a non-related party consultant in exchange for consulting services pursuant to a March 15, 2021 agreement. The shares were valued at $130,000 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 100,000 shares of common stock to a non-related party consultant in exchange for consulting services pursuant to a March 15, 2021 agreement. The shares were valued at $130,000 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 50,000 shares of common stock to a non-related party consultant in exchange for consulting services pursuant to a March 15, 2021 agreement. The shares were valued at $65,000 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 25,000 shares of common stock to a non-related party consultant in exchange for consulting services pursuant to a March 15, 2021 agreement. The shares were valued at $32,500 based on OTC’s closing trade price on the date of the agreement. On June 8, 2021, the Company issued 100,000 shares of restricted common stock to a consultant, pursuant to a consulting agreement dated November 15, 2019, for services performed as COO of the Company. The shares were valued at $200,000 based on OTC’s closing trade price on the effective date of the agreement. On June 8, 2021, the Company issued 50,000 shares of restricted common stock to a consultant, pursuant to a consulting agreement dated December 1, 2020, for services performed as Corporate Communications Officer of the Company. The shares were valued at $34,000 based on OTC’s closing trade price on the effective date of the agreement. Common Stock to be issued On November 15, 2019, the Company agreed to issue 100,000 common shares to a former Independent Director of the Company, William Creekmur, in exchange for consulting services. The shares were valued based on OTC’s closing trade price on the date of the agreement. The Company issued 50,000 of the shares on April 20, 2020. The remaining 50,000 shares valued at $100,000 have not been issued and are included in Stock payable as of October 31, 2021, and 2020. During the year ended July 31, 2021, the Company sold 356,000 shares of common stock at $2.00 per share for proceeds of $712,000. The shares were not issued as of July 31, 2021 and $712,000 is included in Stock payable as of July 31, 2021 and were issued by October 31, 2021. The Company also issued warrants to purchase 356,000 shares of common stock at an exercise price of $3.00 per share, with an expiration date on the second anniversary of the date of issuance. Warrants In July 2021, in conjunction with sale of common stock to be issued, the Company issued warrants (the “Warrants”) to purchase 356,000 shares of common stock. The Warrants have an exercise price of $3,00 per share and an expiration date on the second- year anniversary of their issuance. A summary of the Company’s warrant activity and related information for the eyer ended July 31, 2021 is as follows: Number of Warrants Weighted average exercise price Outstanding beginning of year - $ - Granted 356,000 $ 3.00 Outstanding and exercisable, end of year 356,000 $ 3.00 The Company is in negotiations with the IRS regarding its payroll taxes as of October 31, 2021. The amount that is reported in the financial statements is the outstanding amount owed to the IRS but the company feels that there is an error in the calculation and may be able to reduce that amount. There is currently no other pending or threatened litigation.

Sales concentration

Sales concentration	3 Months Ended
	Oct. 31, 2021
Sales concentration
Note - 10 Sales concentration	10. Sales concentration For the three months ended October 31, 2021 and 2020, respectively, 100% of our revenue of $4,500 and $40,954 is from the land use rental income from SDGE (see Note 2). SDGE, for the most part, vacated the property in October 2020.

Gain on Forgiveness of payable

Gain on Forgiveness of payable	3 Months Ended
	Oct. 31, 2021
Gain on Forgiveness of payable
Note - 11 Gain on Forgiveness of payable	11. Gain on Forgiveness of payable For the three months ended October 31,2021, the company recognized a gain of $180,000 related to a forgiveness of payables from a company that was contracted to perform consulting services related to the accounting and preparation of the company’s quarterly financials. The company received written from the consultant notifying the company of the forgiveness.

Subsequent Events

Subsequent Events	3 Months Ended
	Oct. 31, 2021
Gain on Forgiveness of payable
Note - 12 Subsequent Events	12. Subsequent Events The company had no significant subsequent events as of the filing date.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	3 Months Ended
	Oct. 31, 2021
Significant Accounting Policies
Basis of Presentation	These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. Certain amounts from the July 31, 2021 annual report have been reclassified to conform to the presentation used in the current period.
Principles of Consolidation	These financial statements include the accounts of the Company and its subsidiaries. Subsidiaries are all entities (including structured entities) which the Company controls. For accounting purposes, control is established by an investor when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power over the entity. All inter-company balances and transactions are eliminated.
Use of Estimates	The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash and Cash Equivalents	The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance and trust funds to be cash equivalents.
Inventory	Inventory is carried at the lower of cost or net realizable value, with the cost being determined on a first-in, first-out (FIFO) basis. The Company periodically reviews physical inventory and will record a reserve for excess and/or obsolete inventory if necessary. During the three months end October 31, 2021, the company harvested approximately 30,000 and 40,000 pounds of flower and a great deal more of seconds and biomass. During the three months ended October 31, 2021, the Company recognized inventory costs of $175,956 includes raw materials, labor, overhead and other.
Impairment of Long-Lived Assets	The Company evaluates the recoverability of its fixed assets and other assets in accordance with ASC 360-10-15, Impairment or Disposal of Long-Lived Assets
Related Party Transactions	The Company follows ASC 850, Related Party Disclosures
Income Taxes	The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
Foreign Currency Translation	The Company’s functional and reporting currency is the U.S. dollar. Transactions in foreign currencies are translated into the currency of measurement at the exchange rates in effect on the transaction date. Monetary balance sheet items expressed in foreign currencies are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in the statement of operations.
Financial Instruments and Fair Value Measures	ASC 820, “Fair Value Measurements and Disclosures”, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets), or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, loans payable, and amounts due to related parties. Pursuant to ASC 820, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
Stock-based Compensation	The Company records stock-based compensation in accordance with ASC 718, “Compensation – Stock Compensation” and ASC 505, “Equity Based Payments to Non-Employees”, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.
Revenue and Deferred Revenue	In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) which amended the existing accounting standards for revenue recognition. ASU 2014-09 establishes principles for recognizing revenue upon the transfer of promised goods or services to customers, in an amount that reflects the expected consideration received in exchange for those goods or services. As of the date of this report, the Company has not recognized any revenue related to the hemp production business. For the three months ended October 31, 2021, the company recognized $4,500 in rental income from San Diego Gas and Electric Company (“SDGE”) for land usage. For the three months ended October 31, 2020, revenue recognized of $40,954 is related to the land use rental income from SDGE. SDGE vacated the property in October 2020. As of July 31, 2020, the Company recorded deferred revenue of $15,973, representing a portion of the payment received in July 2020, that pertains to August 2020 rental income and accordingly has been recognized and is included in the revenue for the three months ended October 31, 2020.
Leases	The Company evaluates lease assets and lease liabilities, (if any), pursuant to ASC 842, by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing transactions. As of the date of this report, the Company has no material transactions to report.
Loss Per Share	The Company computes earnings (loss) per share in accordance with ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing earnings (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of October 31, 2021, the Company does not have any potentially dilutive shares.
Comprehensive Loss	ASC 220, “Comprehensive Income”, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements.
Recent Accounting Pronouncements	In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases. The amendments in ASU 2018-10 provide additional clarification and implementation guidance on certain aspects of the previously issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) and have the same effective and transition requirements as ASU 2016-02. Upon the effective date, ASU 2018-10 will supersede the current lease guidance in ASC Topic 840, Leases. Under the new guidance, lessees will be required to recognize for all leases, with the exception of short-term leases, a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis. Concurrently, lessees will be required to recognize a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. ASU 2018-10 is effective for private companies and emerging growth public companies for interim and annual reporting periods beginning after December 15, 2019, with early adoption permitted. The guidance is required to be applied using a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative periods presented in the financial statements. During the three months ended October 31, 2021, the Company assessed the impact this guidance had on its financial statements and concluded that at present ASU No. 2018-10 has no impact on its financial statements.

Fixed assets (Tables)

Fixed assets (Tables)	3 Months Ended
	Oct. 31, 2021
Fixed assets (Tables)
Schedule of fixed assets	Useful Life Balance at July 31, 2021 Additions Accumulated Depreciation Balance at October 31, 2021 Production equipment 5 years $ 854,899 $ 35,023 $ (53,848 ) $ 836,785 Furniture and office equipment 5 years 4,859 - (408 ) 4,451 Buildings and improvements 15 years 450,206 - (8,183 ) 442,023 Land 4,212,362 - - 4,212,362 $ 5,522,326 $ 35,023 $ (62,439 ) $ 5,494,912

Loans Payable (Tables)

Loans Payable (Tables)	3 Months Ended
	Oct. 31, 2021
Loans Payable
Schedule of outstanding notes payable	October 31, 2021 July 31, 2021 Secured Promissory Note payable, interest at 15%, matures August 15, 2024 $ 1,760,000 $ 1,760,000 Secured Promissory Note payable, interest at 6%, matures August 23, 2024 2,750,000 2,750,000 Promissory Note, interest at 5.66%, matures October 1, 2023 96,116 112,012 Paycheck Protection Program loan 444,850 444,850 Secured Promissory Note Payable, Interest at 15%, matures June 15, 2022, net of discount $4,119 2,664,629 2,660,186 Promissory Note, interest at 4.75%, matures March 2, 2022 406,137 406,137 Sub- total notes payable 8,121,732 8,133,185 Less long-term portion 4,559,694 7,235,776 Current portion of notes payable $ 3,562,038 $ 897,409

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Oct. 31, 2021
Related Party Transactions
Schedule of reimbursements received	Balance July 31, 2021 $ 3,128,462 Advances 423,171 Reimbursements (77,913 ) Balance October 31, 2021 $ 3,473,720
Schedule of expenses due to related parties	Three months ended October 31, 2021 Three months ended October 31, 2020 CEO, parent $ 90,000 $ 22,500 Chief Technology Officer 7,500 7,500 Chief Financial Officer 22,500 Chief Project Manager 22,500 Chief Communications Manager 15,097 Chief Operating Officer 22,500 22,500 $ 180,097 $ 52,500
Schedule of expenses and payments	Balance at July 31, 2021 Additions Payments Balance at October 31, 2021 CEO, parent $ 180,000 $ 90,000 $ - $ 270,000 Chief Technology Officer (7,500 ) 7,500 5,000 (5,000 ) Chief Operating Officer 113,679 22,500 28,500 107,679 Chief Financial Officer - 22,500 4,250 18,250 Chief Project Manager 40,468 22,500 7,500 55,468 Chief Communications Officer - 15,097 10,000 5,097 Former CEO, subsidiary 67,500 - - 67,500 Former President, subsidiary 67,500 - - 67,500 Former Chief Agricultural Officer, subsidiary 27,144 - - 27,144 Former Director 35,000 - - 35,000 $ 523,791 $ 180,097 $ 55,250 $ 648,638

CommitmentsContingencies (Table

CommitmentsContingencies (Tables)	3 Months Ended
	Oct. 31, 2021
Loans Payable
Summary of warrent activity	Number of Warrants Weighted average exercise price Outstanding beginning of year - $ - Granted 356,000 $ 3.00 Outstanding and exercisable, end of year 356,000 $ 3.00

Nature of Operations and Cont_2

Nature of Operations and Continuance of Business (Details Narrative) - USD ($)	3 Months Ended
	Oct. 31, 2021	Jul. 31, 2021
Accumulated Deficit	$ (59,490,450)	$ (58,885,730)
Cultivation and branding enterprise [Member]
Description, ordinary agricultural commodity	The Company is an innovative, full-scope, science-driven, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for cannabidiol (“CBD”). The Hemp Farming Act of 2018 removed hemp from Schedule I controlled substances (defined as cannabis with less than 0.3% THC), making it an ordinary agricultural commodity.
Accumulated Deficit	$ (59,490,450)
Working capital deficit	$ (8,328,192)

Significant Accounting Polici_3

Significant Accounting Policies (Details Narrative)	3 Months Ended
	Oct. 31, 2021USD ($)	Oct. 31, 2021GBP (£)	Oct. 31, 2020USD ($)	Jul. 31, 2020USD ($)
Deferred revenue				$ 15,973
Harvested flower | £		£ 30,000
Biomass | £		£ 40,000
Inventory costs			$ 175,956
Revenues	$ 4,500		40,954
San Diego Gas and Electric [Member] | Financing Agreement [Member]
Revenues	$ 4,500		$ 40,954

Prepaid expenses (Details Narra

Prepaid expenses (Details Narrative) - Financing Agreement [Member] - GHS Investments LLC [Member]	Sep. 13, 2020USD ($)shares
Restricted Stock, Shares Issued | shares	150,857
Restricted Stock shares issued, value | $	$ 155,383

Fixed Assets (Details)

Fixed Assets (Details) - USD ($)	3 Months Ended	12 Months Ended
	Oct. 31, 2021	Jul. 31, 2021
Production equipment	$ 836,785	$ 854,899
Furniture and office equipment	4,451	4,859
Buildings and improvements	442,023	450,206
Land	4,212,362	4,212,362
Purchase of fixed assets	$ 5,494,912	$ 5,522,326
Useful Life [Member]
Production equipment	5 years
Furniture and office equipment, useful life	5 years
Buildings and improvements	15 years
Additions [Member]
Furniture and office equipment	$ 0
Buildings and improvements	0
Land	0
Production equipment	35,023
Purchase of fixed assets	35,023
Accumulated Depreciation [Member]
Furniture and office equipment	(408)
Purchase of fixed assets	(62,439)
Production equipment	(53,848)
Buildings and improvements	(8,183)
Land	$ 0

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)	3 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Fixed Assets (Details Narrative)
Depreciation expense	$ 62,439	$ 30,177

Loans Payable (Details)

Loans Payable (Details) - USD ($)	Oct. 31, 2021	Jul. 31, 2021
Promissiory Note One [Member]
Notes payable	$ 96,116	$ 112,012
Promissiory Note Two [Member]
Notes payable	406,137	406,137
Secured Promissory Note Payable [Member]
Notes payable	1,760,000	1,760,000
Secured Promissory Note Payable One [Member]
Notes payable	2,750,000	2,750,000
Paycheck Protection Program Loan [Member]
Notes payable	444,850	444,850
Secured Promissory Note Payable Three [Member]
Notes payable	2,664,629	2,660,186
Notes Payable Outstanding [Member]
Notes payable	8,121,732	8,133,185
Less long-term portion	4,559,694	7,235,776
Current portion of notes payable	$ 3,562,038	$ 897,409

Loans Payable (Details Narrativ

Loans Payable (Details Narrative) - USD ($)	Mar. 02, 2021	Dec. 15, 2020	Aug. 15, 2019	Apr. 30, 2020	Aug. 23, 2019	Oct. 31, 2021	Oct. 31, 2020	Jul. 31, 2021	Sep. 12, 2019
Promissory note interest expense						$ 4,863
Interest expense other						100,078
Promissory note issued for acquisation	$ 406,137
Interest rate	4.75%
Current liabilities						8,548,996		$ 8,322,776
Debt discount						4,444	$ 0
Secured Promissory Note One [Member]
Notes payable		$ 2,668,748			$ 2,750,000
Interest rate		15.00%			6.00%
Maturity date		Jun. 15, 2022			Aug. 23, 2024
Unamortized debt discount						4,119
Debt discount		$ 25,688
Repayment of related party debt						$ 1,140,000
Secured Promissory Note [Member]
Notes payable			$ 1,760,000
Interest rate			15.00%
Maturity date			Aug. 15, 2024
Paycheck Protection Program [Member]
Notes payable									$ 183,031
Proceeds from issuance of debt				$ 444,850
Interest rate				1.00%		5.66%
Description, of loan provided				provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business
Monthly payments						$ 4,290
Maturity period						48 years
Current liabilities						$ 46,422
Long-term liabilities						$ 65,591

Convertible Note Payable (Detai

Convertible Note Payable (Details Narrative) - USD ($)	Jan. 08, 2020	Aug. 19, 2020	Mar. 31, 2020	Feb. 20, 2020	Dec. 31, 2019
Principal amount		$ 200,000
Paycheck Protection Program [Member]
Principal amount			$ 500,000
Discounted convertible promissory note	$ 750,000
Share price	$ 2.50
Conversion price	$ 2.50
Common stock purchase warrant	250,000
Interest rate	10.00%
common stock, exercise price	$ 3
Amendment description	The Note can be prepaid at any time by paying 110% of the then outstanding principal, interest, default interest (if any), and any other amounts then due under the Note. The Note is initially convertible at a price per share equal to $2.50 (the “Fixed Conversion Price”); provided, however, that during the continuance of an event of default under the Note, the conversion price shall be equal to 75% of the lowest trading price of the Company’s common stock during the 30 trading days prior to conversion		(ii) the maturity date of the Note was extended to August 20, 2020, (iii) the conversion price of the Note was established as 75% of the lowest trading price of our common stock during the 30 trading days prior to conversion
Initial purchase price					$ 100,000
Proceeds from debt					85,000
Warrant, purchase price	$ 600,000
Fees					$ 15,000
Original issue discount				$ 150,000
Paid the purchase price				$ 500,000
Payment of debt			$ 250,000

Related Party Transactions (Det

Related Party Transactions (Details) - Alita [Member]	3 Months Ended
	Oct. 31, 2021USD ($)
Due to related party debt, beginning balance	$ 3,128,462
Advances	423,171
Reimbursements	(77,913)
Due to related party debt, ending balance	$ 3,473,720

Related Party Transactions (D_2

Related Party Transactions (Details 1) - USD ($)	3 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Related party expense	$ 180,097	$ 52,500
Chief Project Manager [Member]
Related party expense	22,500
CEO, Parent [Member]
Related party expense	90,000	22,500
Chief Technology Officer [Member]
Related party expense	7,500	7,500
Chief Financial Officer [Member]
Related party expense	22,500
Chief Communications Manager [Member]
Related party expense	15,097
Chief Operating Officer [Member]
Related party expense	$ 22,500	$ 22,500

Related Party Transactions (D_3

Related Party Transactions (Details 2)	3 Months Ended
	Oct. 31, 2021USD ($)
Payment of related party expenses beginning	$ 523,791
Additions	180,097
Payments	55,250
Payment of related party expenses ending	648,638
Former Director [Member]
Payment of related party expenses beginning	35,000
Additions	0
Payments	0
Payment of related party expenses ending	35,000
Former President, Subsidiary [Member]
Payment of related party expenses beginning	67,500
Additions	0
Payments	0
Payment of related party expenses ending	67,500
Chief Operating Officer [Member]
Payment of related party expenses beginning	113,679
Additions	22,500
Payments	28,500
Payment of related party expenses ending	107,679
Chief Financial Officer [Member]
Payment of related party expenses beginning	0
Additions	22,500
Payments	4,250
Payment of related party expenses ending	18,250
Chief Project Manager [Member]
Payment of related party expenses beginning	40,468
Additions	22,500
Payments	7,500
Payment of related party expenses ending	55,468
Former Chief Agricultural Officer, Subsidiary [Member]
Payment of related party expenses beginning	27,144
Additions	0
Payments	0
Payment of related party expenses ending	27,144
Former CEO, Subsidiary [Member]
Payment of related party expenses beginning	67,500
Additions	0
Payments	0
Payment of related party expenses ending	67,500
Chief Technology Officer [Member]
Payment of related party expenses beginning	(7,500)
Additions	7,500
Payments	5,000
Payment of related party expenses ending	(5,000)
Chief Communications Officer [Member]
Payment of related party expenses beginning	0
Additions	15,097
Payments	10,000
Payment of related party expenses ending	5,097
CEO, Parent [Member]
Payment of related party expenses beginning	180,000
Additions	90,000
Payments	0
Payment of related party expenses ending	$ 270,000

Related Party Transactions (D_4

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Sep. 21, 2020	Oct. 31, 2021	Oct. 31, 2020
Imputed interest		$ 80,275	$ 76,778
Common stock shares issued, value		$ 0	$ 1,500
Alita [Member]
Business aquisition, consideration transferred, percentage		50.00%
Chief Project Manager [Member]
Shares issued upon exchange of production equipment	50,000
Common stock shares issued, value	$ 51,500

Share Issuances (Details Narrat

Share Issuances (Details Narrative) - USD ($)	Jun. 08, 2021	Mar. 15, 2021	Mar. 10, 2021	Jan. 15, 2021	Sep. 13, 2020	Sep. 02, 2020	Feb. 17, 2021	Nov. 15, 2020	Sep. 29, 2020	Sep. 21, 2020	Oct. 31, 2021	Oct. 31, 2020	Jul. 31, 2021
Common stock shares issued to related party, amount												$ 155,383	$ 69,600
Stock-based compensation expense													355,550
CFO of the Company [Member]
Common stock shares issued to related party, shares										50,000
Common stock shares issued to related party, amount										$ 60,750
Non related third party [Member]
Common stock shares issued to related party, shares	50,000								140,000
Common stock shares issued to related party, amount	$ 44,500								$ 137,200
Consulting Agreement [Member]
Common stock shares issued to related party, shares	75,000			100,000			125,000	125,000		200,000
Common stock shares issued to related party, amount	$ 97,500			$ 75,000			$ 113,750	$ 75,000		$ 92,000
SRAX [Member]
Shares issued in exchage for right to use assets, shares						500,000
Shares issued in exchage for right to use assets, value						$ 355,550
Financing agreement with GHS [Member]
Common stock shares issued to related party, shares					150,857
Common stock shares issued to related party, amount					$ 155,383
Stock-based compensation expense											$ 155,383		$ 155,383
Assistant Agricultural Operations Manager [Member]
Common stock shares issued to related party, shares										25,000
Common stock shares issued to related party, amount										$ 37,000
Chief Project Manager [Member]
Common stock shares issued to related party, shares										100,000
Common stock shares issued to related party, amount										$ 148,000
Chief Science Officer [Member]
Common stock shares issued to related party, shares	100,000									100,000
Common stock shares issued to related party, amount	$ 87,250									$ 87,250
Placement agreement with BSL [Member]
Common stock shares issued to related party, shares										187,500
Common stock shares issued to related party, amount										$ 250,000
Relatives of Chief Project Manager [Member]
Common stock shares issued to related party, shares										50,000
Common stock shares issued to related party, amount										$ 51,500
Consultants 2 [Member]
Common stock shares issued to related party, shares	50,000									125,000
Common stock shares issued to related party, amount	$ 34,000									$ 113,500
Consultants 3 [Member]
Common stock shares issued to related party, shares										187,000
Common stock shares issued to related party, amount										$ 100,000
Shareholder [Member]
Common stock shares issued to related party, shares										125,000
Common stock shares issued to related party, amount										$ 185,000
Consultants 1 [Member]
Common stock shares issued to related party, shares	100,000									125,000
Common stock shares issued to related party, amount	$ 200,000									$ 113,750
Consultants [Member]
Common stock shares issued to related party, shares	100,000	260,000	200,000							50,000
Common stock shares issued to related party, amount	$ 200,000	$ 338,000	$ 206,000							$ 58,500
CEO [Member]
Common stock shares issued to related party, shares	125,000									250,000
Common stock shares issued to related party, amount	$ 185,000									$ 370,000

Commitments Contigencies (Detai

Commitments Contigencies (Details)	12 Months Ended
	Jul. 31, 2021$ / sharesshares
Commitments Contigencies (Details)
Number of warrants, outstanding beginning of year | shares	0
Number of warrants, granted | shares	356,000
Number of warrants, outstanding and exercisable, end of year | shares	356,000
Weighted average exercise price, outstanding beginning of year | $ / shares	$ 0
Weighted average exercise price, granted | $ / shares	3
Weighted average exercise price, outstanding and exercisable, end of year | $ / shares	$ 3

Commitments Contigencies (Det_2

Commitments Contigencies (Details Narrative) - USD ($)	Jun. 08, 2021	Mar. 15, 2021	Mar. 11, 2021	Mar. 10, 2021	Jan. 15, 2021	Sep. 13, 2020	Sep. 02, 2020	Feb. 17, 2021	Nov. 15, 2020	Sep. 29, 2020	Sep. 21, 2020	Apr. 20, 2020	Oct. 31, 2021	Apr. 30, 2021	Oct. 31, 2020	Apr. 30, 2021	Jul. 31, 2021	Jul. 31, 2020
Common stock shares authorized													375,000,000				375,000,000
Common stock par value													$ 0.001				$ 0.001
Common stock shares issued													44,482,138				44,126,138
Common stock shares outstanding													44,482,138				44,126,138
Restricted common stock shares issued								200,000
Restricted common stock, value								$ 296,000
Proceeds from sale of stock																	$ 712,000
Stock-based compensation																	$ 355,550
Purchase shares of common stock																	356,000
Exercise price per warranty													$ 3				$ 3
Common stock shares to be issued									100,000			50,000					50,000	50,000
Common stock value to be issued																	100,000	100,000
Common stock shares issued to related party, amount															$ 155,383		$ 69,600
Inventory													$ 175,957				0
CFO of the Company [Member]
Common stock shares issued to related party, amount											$ 60,750
Common stock shares issued to related party, shares											50,000
Non related third party [Member]
Common stock shares issued to related party, amount	$ 44,500									$ 137,200
Common stock shares issued to related party, shares	50,000									140,000
Non related third party 3 [Member]
Common stock shares issued to related party, amount	$ 130,000							$ 296,000	$ 200,000
Common stock shares issued to related party, shares	100,000							200,000	100,000
Non related third party 1 [Member]
Common stock shares issued to related party, amount	$ 15,125							$ 296,000	$ 200,000
Common stock shares issued to related party, shares	12,500							200,000	100,000
Non related third party 2 [Member]
Common stock shares issued to related party, amount	$ 130,000							$ 296,000	$ 200,000
Common stock shares issued to related party, shares	100,000							200,000	100,000
Non related third party 4 [Member]
Common stock shares issued to related party, amount	$ 130,000							$ 296,000	$ 200,000
Common stock shares issued to related party, shares	100,000							200,000	100,000
Non related third party 5 [Member]
Common stock shares issued to related party, amount	$ 65,000							$ 296,000	$ 200,000
Common stock shares issued to related party, shares	50,000							200,000	100,000
Non related third party 6 [Member]
Common stock shares issued to related party, amount	$ 32,500							$ 296,000	$ 200,000
Common stock shares issued to related party, shares	25,000							200,000	100,000
Consulting Agreement [Member]
Common stock shares issued to related party, amount	$ 97,500				$ 75,000			$ 113,750	$ 75,000		$ 92,000
Common stock shares issued to related party, shares	75,000				100,000			125,000	125,000		200,000
Consulting Agreement [Member] | December 1, 2020 [Member]
Common stock shares issued to related party, amount																	$ 34,000
Common stock shares issued to related party, shares																	50,000
Consulting Agreement 1 [Member]
Common stock shares issued to related party, amount								$ 296,000	$ 200,000
Common stock shares issued to related party, shares								200,000	100,000
September 21, 2020 [Member] | Consulting Agreement [Member]
Common stock shares to be issued																200,000
SRAX [Member]
Shares issued in exchage for right to use assets, shares							500,000
Shares issued in exchage for right to use assets, value							$ 355,550
Financing agreement with GHS [Member]
Stock-based compensation													$ 155,383				$ 155,383
Common stock shares issued to related party, amount						$ 155,383
Common stock shares issued to related party, shares						150,857
Assistant Agricultural Operations Manager [Member]
Common stock shares issued to related party, amount											$ 37,000
Common stock shares issued to related party, shares											25,000
Assistant Agricultural Operations Manager [Member] | September 21, 2020 [Member]
Common stock shares to be issued																25,000
Assistant Agricultural Operations Manager [Member] | August 1, 2019 [Member]
Common stock shares to be issued																25,000
Chief Science Officer [Member]
Common stock shares issued to related party, amount	$ 87,250										$ 87,250
Common stock shares issued to related party, shares	100,000										100,000
Placement agreement with BSL [Member]
Common stock shares issued to related party, amount											$ 250,000
Common stock shares issued to related party, shares											187,500
Relatives of Chief Project Manager [Member]
Common stock shares issued to related party, amount											$ 51,500
Common stock shares issued to related party, shares											50,000
Consultants 2 [Member]
Common stock shares issued to related party, amount	$ 34,000										$ 113,500
Common stock shares issued to related party, shares	50,000										125,000
Shareholder [Member]
Common stock shares issued to related party, amount											$ 185,000
Common stock shares issued to related party, shares											125,000
Consultants 1 [Member]
Common stock shares issued to related party, amount	$ 200,000										$ 113,750
Common stock shares issued to related party, shares	100,000										125,000
Consultants [Member]
Common stock shares issued to related party, amount	$ 200,000	$ 338,000		$ 206,000							$ 58,500
Common stock shares issued to related party, shares	100,000	260,000		200,000							50,000
CEO [Member]
Common stock shares issued to related party, amount	$ 185,000										$ 370,000
Common stock shares issued to related party, shares	125,000										250,000
COO [Member]
Common stock shares to be issued														100,000
Chief Project Manager [Member]
Common stock shares issued to related party, amount											$ 148,000
Common stock shares issued to related party, shares											100,000
Chief Project Manager [Member] | September 21, 2020 [Member]
Common stock shares to be issued																100,000
Chief Project Manager [Member] | August 1, 2019 [Member]
Common stock shares to be issued																200,000
Assets Purchase Agreement [Member]
Restricted common stock shares issued			60,000
Restricted common stock, value			$ 69,600
Inventory			$ 69,400

Sales Concentration (Details Na

Sales Concentration (Details Narrative) - USD ($)	3 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
Revenue	$ 4,500	$ 40,954
San Diego Gas and Electric [Member] | Financing Agreement [Member]
Revenue	$ 4,500	$ 40,954
Rental income land use	100.00%

Gain on Forgiveness of payable

Gain on Forgiveness of payable (Details Narrative)	3 Months Ended
	Oct. 31, 2021USD ($)
Sales Concentration (Details Narrative)
Gain on forgiveness of payable	$ 180,000